27 related articles for article (PubMed ID: 2993776)
1. Vanadate-Induced Renal cAMP and Malondialdehyde Accumulation Suppresses Alpha 1 Sodium Potassium Adenosine Triphosphatase Protein Levels.
Eiam-Ong S; Nakchui Y; Chaipipat M; Eiam-Ong S
Toxicol Res; 2018 Apr; 34(2):143-150. PubMed ID: 29686776
[TBL] [Abstract][Full Text] [Related]
2. Effects of carbamylcholine on membrane potential and Na-K pump activity of cultured rat skeletal myotubes.
Brodie C; Sampson SR
Cell Mol Neurobiol; 1988 Dec; 8(4):393-410. PubMed ID: 2852060
[TBL] [Abstract][Full Text] [Related]
3. Veratridine-induced oscillations in membrane potential of cultured rat skeletal muscle: role of the Na-K pump.
Brodie C; Sampson SR
Cell Mol Neurobiol; 1990 Jun; 10(2):217-26. PubMed ID: 2163752
[TBL] [Abstract][Full Text] [Related]
4. Greater sensitivity to vanadate of rat renal relative to cardiac (Na+ + K+)-ATPase.
Clough DL
Life Sci; 1984 Nov; 35(19):1937-46. PubMed ID: 6092807
[TBL] [Abstract][Full Text] [Related]
5. Dog kidney (Na+,K+)-ATPase is more sensitive to inhibition by vanadate than human red cell (Na+,K+)-ATPase.
Bond GH; Hudgins PM
Biochim Biophys Acta; 1981 Sep; 646(3):479-82. PubMed ID: 6269617
[TBL] [Abstract][Full Text] [Related]
6. Vanadate effect on the Na,K-ATPase and the Na-K pump in in vitro-grown rat vascular smooth muscle cells.
Searle BM; Higashino H; Khalil F; Bogden JD; Tokushige A; Tamura H; Kino M; Aviv A
Circ Res; 1983 Aug; 53(2):186-91. PubMed ID: 6309430
[TBL] [Abstract][Full Text] [Related]
7. Vanadium, Na-K-ATPase, and potassium adaptation in the rat.
Higashino H; Bogden JD; Lavenhar MA; Bauman JW; Hirotsu T; Aviv A
Am J Physiol; 1983 Feb; 244(2):F105-11. PubMed ID: 6297310
[TBL] [Abstract][Full Text] [Related]
8. Low-affinity Na+ sites on (Na+ +K+)-ATPase modulate inhibition of Na+-ATPase activity by vanadate.
Bond GH; Hudgins PM
Biochim Biophys Acta; 1982 May; 687(2):310-4. PubMed ID: 6284222
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat cardiac and renal Na+,K+-ATPase by high sodium concentrations and vanadate.
Clough DL
Life Sci; 1985 Sep; 37(9):799-807. PubMed ID: 2993776
[TBL] [Abstract][Full Text] [Related]
10. Vanadate and phosphotransferases with special emphasis on ouabain/na,k-atpase interaction.
Hansen O
Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 1():1-19. PubMed ID: 6301215
[No Abstract] [Full Text] [Related]
11. The role of a humoral Na+,K+-ATPase inhibitor in regulating precapillary vessel tone.
Haddy FJ
J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S439-56. PubMed ID: 6206353
[TBL] [Abstract][Full Text] [Related]
12. The role of Na,K-ATPase inhibitors in hypertension and end-stage renal disease.
Bargman JM
Perit Dial Int; 1997; 17(6):536-40. PubMed ID: 9655151
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
